Stem Cell Banking Market Competitive Landscape, Size, Segments, and Growth by 2031

Coverage: Stem Cell Banking Market covers analysis by Source (Placental Stem Cells (PSCS), Dental Pulp-Derived Stem Cells (DPSCS), Bone Marrow-Derived Stem Cells (BMSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Human Embryo-Derived Stem Cells (HESCS), and Other Stem Cell Sources), Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Clinical Applications, Research Applications, and Personalized Banking Applications), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPBT00002082
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Stem Cell Banking Market Growth Report 2021-2031

Buy Now

The Stem Cell Banking Market is expected to register a CAGR of 15.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.

The report is segmented based on Source (Placental Stem Cells, Dental Pulp-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Adipose Tissue-Derived Stem Cells, Human Embryo-Derived Stem Cells, Other Stem Cell Sources), Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation) and Application (Clinical Applications, Research Applications, Personalized Banking Applications). The global analysis is further broken down at the regional level and major countries. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Stem Cell Banking Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Stem Cell Banking Market Segmentation

Source
  • Placental Stem Cells
  • Dental Pulp-Derived Stem Cells
  • Bone Marrow-Derived Stem Cells
  • Adipose Tissue-Derived Stem Cells
  • Human Embryo-Derived Stem Cells
  • Other Stem Cell Sources
Service Type
  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation
Application
  • Clinical Applications
  • Research Applications
  • Personalized Banking Applications
Geography
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa
Geography
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Strategic Insights

Stem Cell Banking Market Growth Drivers
  • Advancements in Stem Cell Research: Ongoing research is unlocking the potential of stem cells in regenerative medicine.
  • Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases is driving demand for stem cell therapies.
  • Growing Awareness and Acceptance: Increasing public awareness and acceptance of stem cell technology are fueling market growth.
Stem Cell Banking Market Future Trends
  • Personalized Medicine: The integration of personalized medicine approaches, such as genetic testing and biomarker analysis, can enhance the efficacy and safety of stem cell therapies.
  • Ethical Considerations and Regulatory Framework: The development of robust ethical guidelines and regulatory frameworks for stem cell research and banking will be crucial for industry growth.
  • Combination Therapies: Integrating stem cell therapies with other treatments for enhanced efficacy.
Stem Cell Banking Market Opportunities
  • Expansion into Emerging Markets: Emerging markets with growing healthcare infrastructure and increasing disposable incomes offer significant growth opportunities for stem cell banks.
  • Development of Novel Stem Cell Therapies: The development of novel stem cell-based therapies for diseases like Parkinson's, Alzheimer's, and diabetes can create new market opportunities.
  • Diversification into Related Services: Providing additional services like genetic testing and cord blood screening.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Stem Cell Banking Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Stem Cell Banking Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography
Strategic Insights Access Data

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
   Inquire for Discount   
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
life-sciences Access Data
Research Criteria
   Inquire for Discount   
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the deliverable formats of the Stem Cell Banking Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Which are the leading players operating in the Stem Cell Banking Market?

The leading players of the Stem Cell Banking Market are: Cordlife, ViaCord A Subsidiary of PerkinElmer, Cryo Save AG, StemCyte India Therapeutics Pvt Ltd, Cryo Cell International Inc, SMART CELLS PLUS, Vita 34, LifeCell, Global Cord Blood Corporation

What are the future trends of the Stem Cell Banking Market?

The future trends of the Stem Cell Banking Market are: Personalized Medicine and Ethical Considerations and Regulatory Framework

What is the expected CAGR of the Stem Cell Banking Market?

Stem Cell Banking Market is expected to grow at a CAGR of 15.5% between 2023-2031

What are the driving factors impacting the Stem Cell Banking Market?

The driving factors impacting the Stem Cell Banking Market are: Increasing Awareness of Regenerative Medicine and Advancements in Stem Cell Research

Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. STEM CELL BANKING MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Stem Cell Banking Market - By Source
3.2.2. Stem Cell Banking Market - By Service Type
3.2.3. Stem Cell Banking Market - By Application
3.2.4. Stem Cell Banking Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. STEM CELL BANKING MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. STEM CELL BANKING MARKET - GLOBAL ANALYSIS
5.1. GLOBAL STEM CELL BANKING MARKET OVERVIEW
5.2. GLOBAL STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS

6. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY SOURCE
6.1. OVERVIEW
6.2. SOURCE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. PLACENTAL STEM CELLS (PSCS) MARKET
6.3.1. Overview
6.3.2. Placental Stem Cells (PSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. DENTAL PULP-DERIVED STEM CELLS (DPSCS) MARKET
6.4.1. Overview
6.4.2. Dental Pulp-Derived Stem Cells (DPSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.5. BONE MARROW-DERIVED STEM CELLS (BMSCS) MARKET
6.5.1. Overview
6.5.2. Bone Marrow-Derived Stem Cells (BMSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.6. ADIPOSE TISSUE-DERIVED STEM CELLS (ADSCS) MARKET
6.6.1. Overview
6.6.2. Adipose Tissue-Derived Stem Cells (ADSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.7. HUMAN EMBRYO-DERIVED STEM CELLS (HESCS) MARKET
6.7.1. Overview
6.7.2. Human Embryo-Derived Stem Cells (HESCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.8. OTHER STEM CELL SOURCES MARKET
6.8.1. Overview
6.8.2. Other Stem Cell Sources Market Revenue Forecasts and Analysis (US$ Mn)

7. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY SERVICE TYPE
7.1. OVERVIEW
7.2. SERVICE TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. SAMPLE PRESERVATION AND STORAGE MARKET
7.3.1. Overview
7.3.2. Sample Preservation and Storage Market Revenue Forecasts and Analysis (US$ Mn)
7.4. SAMPLE ANALYSIS MARKET
7.4.1. Overview
7.4.2. Sample Analysis Market Revenue Forecasts and Analysis (US$ Mn)
7.5. SAMPLE PROCESSING MARKET
7.5.1. Overview
7.5.2. Sample processing Market Revenue Forecasts and Analysis (US$ Mn)
7.6. SAMPLE COLLECTION AND TRANSPORTATION MARKET
7.6.1. Overview
7.6.2. Sample Collection and Transportation Market Revenue Forecasts and Analysis (US$ Mn)

8. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. CLINICAL APPLICATIONS MARKET
8.3.1. Overview
8.3.2. Clinical Applications Market Revenue Forecasts and Analysis (US$ Mn)
8.3.3. Autoimmune Disorders Market
8.3.3.1. Overview
8.3.3.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.3.4. Hematopoietic Disorders Market
8.3.4.1. Overview
8.3.4.2. Hematopoietic Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.3.5. Other Diseases Market
8.3.5.1. Overview
8.3.5.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.4. RESEARCH APPLICATIONS MARKET
8.4.1. Overview
8.4.2. Research Applications Market Revenue Forecasts and Analysis (US$ Mn)
8.4.3. Life Science Research Market
8.4.3.1. Overview
8.4.3.2. Life Science Research Market Revenue Forecasts and Analysis (US$ Mn)
8.4.4. Disease Treatment Studies Market
8.4.4.1. Overview
8.4.4.2. Disease Treatment Studies Market Revenue Forecasts and Analysis (US$ Mn)
8.4.5. Drug Discovery Market
8.4.5.1. Overview
8.4.5.2. Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
8.5. PERSONALIZED BANKING APPLICATIONS MARKET
8.5.1. Overview
8.5.2. Personalized Banking Applications Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
9.1. NORTH AMERICA STEM CELL BANKING MARKET OVERVIEW
9.2. NORTH AMERICA STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
9.4. NORTH AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
9.5. NORTH AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5.1. North America Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.5.2. North America Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.6. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.7.2. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.7.3. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3.1. US Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.3.2. US Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.8.2. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.8.3. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3.1. Canada Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.3.2. Canada Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.9.2. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.9.3. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3.1. Mexico Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.3.2. Mexico Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)

10. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
10.1. EUROPE STEM CELL BANKING MARKET OVERVIEW
10.2. EUROPE STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
10.4. EUROPE STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
10.5. EUROPE STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5.1. Europe Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.5.2. Europe Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.6. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.7.2. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.7.3. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3.1. UK Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.3.2. UK Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.8.2. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.8.3. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3.1. Germany Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.3.2. Germany Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.9.2. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.9.3. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3.1. France Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.3.2. France Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)

11. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC STEM CELL BANKING MARKET OVERVIEW
11.2. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
11.4. ASIA PACIFIC STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
11.5. ASIA PACIFIC STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5.1. Asia Pacific Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.5.2. Asia Pacific Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.6. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.7.2. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.7.3. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3.1. Japan Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.3.2. Japan Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.8.2. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.8.3. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3.1. China Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.3.2. China Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.9.2. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.9.3. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3.1. India Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.3.2. India Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)

12. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5.1. Middle East and Africa (MEA) Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.5.2. Middle East and Africa (MEA) Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.7.2. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.7.3. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3.1. South Africa Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.3.2. South Africa Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.8.2. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.8.3. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3.1. Saudi Arabia Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.3.2. Saudi Arabia Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.9.2. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.9.3. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3.1. UAE Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.3.2. UAE Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)

13. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5.1. South and Central America Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.5.2. South and Central America Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
13.7.2. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
13.7.3. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3.1. Brazil Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.3.2. Brazil Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions

15. STEM CELL BANKING MARKET, KEY COMPANY PROFILES
15.1. CORDLIFE
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. VIACORD (A SUBSIDIARY OF PERKINELMER)
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. CRYO-SAVE AG
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. STEMCYTE INDIA THERAPEUTICS PVT. LTD.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. CRYO-CELL INTERNATIONAL, INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. SMART CELLS PLUS.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. VITA 34
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. LIFECELL
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. GLOBAL CORD BLOOD CORPORATION
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. CBR SYSTEMS, INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Cordlife
2. ViaCord (A Subsidiary of PerkinElmer)
3. Cryo-Save AG
4. StemCyte India Therapeutics Pvt. Ltd.
5. Cryo-Cell International, Inc.
6. SMART CELLS PLUS.
7. Vita 34
8. LifeCell
9. Global Cord Blood Corporation
10. CBR Systems, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..